CHRISTI WILLIAMS: Open Payments
NPI 1215581905 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 68 payments from 20 companies in 2025. Trend: 2023 $1,230 · 2024 $1,700 · 2025 $1,578
Food & beverage: $1,398Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $232 |
| Janssen Biotech, Inc. | 8 | $222 |
| Incyte Corporation | 6 | $174 |
| E.R. Squibb & Sons, L.L.C. | 12 | $156 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Hologic Sales and Service, LLC | 1 | $93 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| Eisai Inc. | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
Products named: VENCLEXTA, OPDIVO, EPKINLY, THINPREP 2000 PROCESSOR, KEYTRUDA, IMJUDO, DARZALEX, Lenvima.
Industry payments across TX — which companies pay providers there.
